SC2i Tissue and Data Repository Protocol
Henry M. Jackson Foundation for the Advancement of Military Medicine · with Uniformed Services University of the Health Sciences, United States Department of Defense · NCT02182180
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 5000
- US sites recruiting
- 4
- Study start
- September 9, 2014
- Record last updated
- September 4, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to collect samples of blood, urine, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and other body fluids and tissues from people who have been seriously injured or ill. The samples will be used to develop and assess tests and/or tools that doctors can use to decide the best treatment plan for seriously injured or ill military personnel and for civilians. Additonal protocols to use the samples will be submitted as separate protocols.
Conditions: Critical Illness
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patients with injury or illness requiring surgical care or treatment in a critical care or emergency setting who are being cared for at SC2I sites (Grady Memorial Hospital, Emory Univeristy Hospital, and Duke University Health Systems)
- Healthy volunteer control subjects to include individuals without any known injury or end-stage organ disease and patients who have recovered from prior injury.
- Ability to understand the purposes and risks of the study and willingly give written informed consent, or in the case of incapacitated patients, a willing surrogate able to give written informed consent.
Exclusion Criteria
- Any condition that, in the opinion of the attending physician, would place the patient or volunteer subject at undue risk by participating. Specific conditions include but are not limited to anemia prohibitive of phlebotomy, coagulopathy, or technical considerations that would prevent acquisition of sufficient tissue or fluid for clinical use. Acquisition of samples from patients requiring active transfusion or with transfusion-associated coagulopathy will be considered as appropriate study candidates at the discretion of the attending physician.
Recruiting US locations
Grady Health Systems
Atlanta, GA 30303
Site contact: Christopher J. Dente, MD · 404-251-8915 · cdente@emory.edu
Emory University
Atlanta, GA 30322
Site contact: Timothy Buchman, MD, PhD · 404-712-2602 · tbuchma@emory.edu
Walter Reed National Military Medical Center
Bethesda, MD 20889
Site contact: Benjamin K Potter, MD, FACS · 301-400-2723 · benjamin.k.potter.mil@mail.mil
Duke University Health Systems
Durham, NC 27710
Site contact: Allan Kirk, MD, PhD · 919-681-4853 · allan.kirk@dm.duke.edu
Similar studies in Georgia
All healthy volunteers studies in Georgia →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Influenza Human Challenge Model
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A/Texas Flu Challenge
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Atlanta, GA + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Decatur, GA + 49 other US sites
- Eligibility basics
- Ages 60+